» Articles » PMID: 21589936

A Translational Regulator, PUM2, Promotes Both Protein Stability and Kinase Activity of Aurora-A

Overview
Journal PLoS One
Date 2011 May 19
PMID 21589936
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aurora-A, a centrosomal serine-threonine kinase, orchestrates several key aspects of cell division. However, the regulatory pathways for the protein stability and kinase activity of Aurora-A are still not completely understood. In this study, PUM2, an RNA-binding protein, is identified as a novel substrate and interacting protein of Aurora-A. Overexpression of the PUM2 mutant which fails to interact with Aurora-A, and depletion of PUM2 result in a decrease in the amount of Aurora-A. PUM2 physically binds to the D-box of Aurora-A, which is recognized by APC/C(Cdh1). Overexpression of PUM2 prevents ubiquitination and enhances the protein stability of Aurora-A, suggesting that PUM2 protects Aurora-A from APC/C(Cdh1)-mediated degradation. Moreover, association of PUM2 with Aurora-A not only makes Aurora-A more stable but also enhances the kinase activity of Aurora-A. Our study suggests that PUM2 plays two different but important roles during cell cycle progression. In interphase, PUM2 localizes in cytoplasm and plays as translational repressor through its RNA binding domain. However, in mitosis, PUM2 physically associates with Aurora-A to ensure enough active Aurora-A at centrosomes for mitotic entry. This is the first time to reveal the moonlight role of PUM2 in mitosis.

Citing Articles

-Regulated Signaling Pathways in Breast Cancer Progression.

Capela A, Tavares-Marcos C, Estima-Arede H, Nobrega-Pereira S, de Jesus B Cancers (Basel). 2024; 16(3).

PMID: 38339387 PMC: 10854850. DOI: 10.3390/cancers16030636.


Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases.

Kumari P, Beeraka N, Tengli A, Bannimath G, Baath R, Patil M Curr Med Chem. 2023; 31(23):3502-3528.

PMID: 37138483 DOI: 10.2174/0929867330666230503124408.


Aurora kinase A, a synthetic lethal target for precision cancer medicine.

Mou P, Yang E, Shi C, Ren G, Tao S, Shim J Exp Mol Med. 2021; 53(5):835-847.

PMID: 34050264 PMC: 8178373. DOI: 10.1038/s12276-021-00635-6.


Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy.

Du R, Huang C, Liu K, Li X, Dong Z Mol Cancer. 2021; 20(1):15.

PMID: 33451333 PMC: 7809767. DOI: 10.1186/s12943-020-01305-3.


Principal Postulates of Centrosomal Biology. Version 2020.

Uzbekov R, Avidor-Reiss T Cells. 2020; 9(10).

PMID: 32987651 PMC: 7598677. DOI: 10.3390/cells9102156.


References
1.
Cotteret S, Chernoff J . Pak GITs to Aurora-A. Dev Cell. 2005; 9(5):573-4. DOI: 10.1016/j.devcel.2005.10.005. View

2.
Carmena M, Earnshaw W . The cellular geography of aurora kinases. Nat Rev Mol Cell Biol. 2003; 4(11):842-54. DOI: 10.1038/nrm1245. View

3.
Walter A, Seghezzi W, Korver W, Sheung J, Lees E . The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation. Oncogene. 2000; 19(42):4906-16. DOI: 10.1038/sj.onc.1203847. View

4.
Littlepage L, Wu H, Andresson T, Deanehan J, Amundadottir L, Ruderman J . Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A. Proc Natl Acad Sci U S A. 2002; 99(24):15440-5. PMC: 137735. DOI: 10.1073/pnas.202606599. View

5.
Kramer E, Scheuringer N, Podtelejnikov A, Mann M, Peters J . Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol Biol Cell. 2000; 11(5):1555-69. PMC: 14867. DOI: 10.1091/mbc.11.5.1555. View